Brief: Vivos Therapeutics Announces Landmark Clinical Trial Results In Pediatric Obstructive Sleep Apnea Treatment
17/09/2025 13:48
Sept 17 (Reuters) - Vivos Therapeutics Inc VVOS.O: VIVOS THERAPEUTICS ANNOUNCES LANDMARK CLINICAL TRIAL RESULTS IN PEDIATRIC OBSTRUCTIVE SLEEP APNEA TREATMENT Source text: ID:nGNX7P4Tm Further company coverage: VVOS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth